Dominant optic atrophy is a genetic optic nerve disorder. The gene that is responsible for this disorder is the OPA1 gene. Patients who have this gene in an inherited genetic mutated form, have mutated mitochondria's in their optic cells resulting in this atrophy. A therapy has been developed by scientists at Trinity College Dublin. This gene therapy consists of injecting genes to help boost the production of these mitochondrion cells resulting in dissipating symptoms. So far this study has only been tested in lab mice, but is proving to be promising. This would be quite a breakthrough for the Optic focused side of the medical field. (Scientists develop new gene therapy for eye disease)
Source: “Scientists Develop New Gene Therapy for Eye Disease.” ScienceDaily, ScienceDaily, 26 Nov. 2020, www.sciencedaily.com/releases/2020/11/201126085921.htm.
Links used:
https://www.sciencedaily.com/releases/2020/11/201126085921.htm
https://www.frontiersin.org/articles/10.3389/fnins.2020.571479/full
No comments:
Post a Comment